Breaks Categories: News

WednesdayOct 20, 2021 11:08 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Study Reveals Effectiveness of Proprietary Drug-Development Tech

Lexaria Bioscience (NASDAQ: LEXX), developers of the revolutionary DehydraTECH(TM) drug-delivery technology, has released study results focused on THC-A21-1, a THC oral format. According to the announcement, the study showed that Lexaria’s DehydraTECH THC solution delivers THC levels to blood plasma an estimated three times faster than standard MCT-based THC. Based on study results, it took only 15 minutes using oral ingestion of the substance to reach THC levels comparable to those reached in 45 minutes using "coconut-oil" formulations. As the THC left the system at the six-hour mark, levels were comparable and demonstrated the fast-on, fast-off performance. The DehydraTECH results are timely…

Continue Reading

WednesdayOct 20, 2021 10:36 am

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Granted Approval to Evaluate Sensory Factors in Product-Development Trials

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) has received an amendment to a cannabis research license it had previously been granted by Health Canada. The amendment allows the company to include sensory evaluations of cannabis beverages in an upcoming product development trial. According to the announcement, the company will be able to  conduct onsite human assessments of the taste, smell, feel and visual appeal of products the company is developing, a move that BevCanna says will provide significant advantages for its white-label clients as well as in-house brands because the new-product trial capabilities are unique in the Canadian cannabis beverage…

Continue Reading

TuesdayOct 19, 2021 12:43 pm

CannabisNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Enters Functional CBD Water Space in the Golden State

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company and The Clean Beverage(R) company, has announced that it will begin sales in California of its six new A88CDB(TM) functional waters after passage of Assembly Bill 45 in the Golden State. The six natural, functional A88CBD waters—Relax, Refresh, Resistance, Relief, Reenergize, and Rest—will be sold through A88 Infused Products Inc., a wholly-owned subsidiary of the company. The product’s innovative packaging utilizes a pressurized Vessl(R) closure that contains 25mg of CBD and other functional vitamins and ingredients, which freshly infuse at 110psi into the alkaline water…

Continue Reading

MondayOct 18, 2021 11:05 am

CannabisNewsBreaks – ‘Queen of Green’ Dr. Kara Coe Provides Business Update Relative to Virginia’s Momentous Policy Shift

The state of Virginia officially legalized the consumption and possession of recreational marijuana in July 2021, a momentous policy shift that followed the state’s opening of its medical marijuana market a little over a year ago. Forensic-psychologist-turned-entrepreneur Dr. Kara Coe, popularly known within professional cannabis circles as the “Queen of Green,” has been on the forefront of the Virginia cannabis movement, most recently through the launch of her diverse cannabis-focused business portfolio. Today, Dr. Coe provided an update on her business endeavors relative to Virginia’s recent recreational cannabis legalization. “Women nurture others by nature, so even though this is a…

Continue Reading

ThursdayOct 14, 2021 1:16 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Completion of BayMedica Acquisition

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has finalized the acquisition of BayMedica Inc., a private company based in the U.S. specializing in the manufacturing and commercialization of rare cannabinoids for the health and wellness sector. INM had announced the acquisition earlier. According to the announcement, the acquisition provides capabilities and resources to accelerate InMed’s commercial initiatives, including the development and unveiling of several new cannabinoids products in the consumer health and wellness sector. The combined technologies include synthetic biology, chemical synthesis and IntegraSyn(TM), a patented enzymatic biotransformation. The company noted that, with…

Continue Reading

ThursdayOct 14, 2021 11:11 am

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Enters Agreement to Bring Averi’s Cannabis-Infused Concepts to Life

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, has announced its entry into an agreement to manufacture and distribute white-label cannabis beverages for Averi Health Products. A new adult alternative beverage company founded by Terry Donnelly, creator and former CEO of the award-winning Hill Street Beverage Co., Averi will launch a portfolio of cannabis-infused beverages into the Canadian market. Under the agreement, Averi will leverage BevCanna’s extensive experience in producing beverages at scale as well as its sales license partnership for distribution to Canadian provincial buying groups. “Averi is…

Continue Reading

WednesdayOct 13, 2021 2:13 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Impressive Findings of Oral THC Absorption Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its recent oral tetrahydrocannabinol (“THC”) absorption study THC-A21-1 revealed that DehydraTECH(TM)-THC delivered via oral ingestion required only 15 minutes to deliver THC levels in blood plasma comparable to levels achieved at 45 minutes with concentration-matched controls. According to the update, DehydraTECH-THC delivered more THC into the bloodstream during the study than the industry standard medium chain triglyceride (“MCT” or “coconut oil”) based control formulation from the two-minute mark onwards, then dropped rapidly to the same level as the MCT control by the six-hour mark. “The…

Continue Reading

WednesdayOct 13, 2021 1:35 pm

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) to Move Forward with Regulatory Approval Process to Bring Hourglass(TM) to All Canadians

Grapefruit USA (OTCQB: GPFT), a premiere California-based cannabis and hemp company, today announced its entry into a formal collaboration with 6PAK Solutions Inc. and Medz Cannabis, Inc., 6PAK’s partner and license holder, to bring Grapefruit’s patented Hourglass(TM) Time Release THC+CBD Delivery Topical Relief Cream to market throughout Canada. According to the update, the formal collaboration agreement cements the strategic alliance with 6PAK Solutions Inc., a well-respected Canadian cannabis manufacturer and arm of ATG Pharma Inc. Under the new alliance, Grapefruit will file its Notice of New Cannabis Product (“NNCP”) with Health Canada detailing the Hourglass production process, including integration of…

Continue Reading

TuesdayOct 12, 2021 2:06 pm

CannabisNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces Preliminary Q2 2022 Results

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company and The Clean Beverage Company(TM), today announced that it anticipates topline revenue of approximately $15 million for the second quarter of fiscal year 2022. According to the update, this would be the best quarter on record and represent almost 50% year-over-year growth. In addition, the company reiterates full fiscal year 2022 revenue guidance of $62 million and will officially report its results for the full second quarter of fiscal year 2022 in November. “We anticipate the second quarter sales of fiscal 2022 will be a…

Continue Reading

TuesdayOct 12, 2021 1:28 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Featured in ‘Stock2Me’ Podcast

Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, was featured in the latest episode of the “Stock2Me Podcast,” an IBN (InvestorBrandNetwork) solution to provide specialized content distribution via widespread syndication channels. Lexaria’s CEO and Chairman Chris Bunka joined the latest episode to discuss the company’s business model, his professional background and the team behind Lexaria, as well as the company’s recent transformative steps to position it for accelerated growth. “Our company kind of had a rebirth in January 2021. … We completed a 1-for-30 reverse stock split,” Bunka explained. “That was really hard, and just…

Continue Reading